Flag risks now to prevent complications later
ECG monitoring enables you to proactively assess cardiac safety risks, which means you can stay on top of cardiac safety concerns that could derail your product’s future and avoid the costs of leaving signals undetected until later, larger studies.
Tools and expertise to help you manage risk
Quintiles has the industry’s largest staff of cardiologists to review, analyze and adjudicate each ECG, and we combine high-capacity, cost-effective ECG monitoring with drug development expertise. The result? An interdisciplinary team that helps you make better decisions earlier – and meet regulatory expectations at each step of development, from First-in-Human studies to regulatory submission.
- Real-time access to ECG reports and summary data using our online portal, with 24/7 investigator and site helpline.
- A proprietary, patent-pending system to flag, manage and quickly resolve data queries.
- Central reading standards that exceed ICH/FDA/EMA guidelines.
We’ve built an unmatched set of ECG monitoring capabilities and a cost-effective process that give sponsors a head start on successful trials.